Clinical trial
Targeting Emotion Regulation in Bipolar Disorder With Intermittent Theta Burst Stimulation: A Mechanistic Study
NCT06274567 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeting Emotion Regulation in Bipolar Disorder With Intermittent Theta Burst Stimulation: A Mechanistic Study
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 20, 2024
- Completion date
- March 31, 2029
- Enrollment
- 136 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.